parallel sessions - International Society for Blood Transfusion

PostersISBT2006PostersTOPIC 01.2TOPIC 01.2P-067 SEROLOGICAL MARKERS FOR HBV INFECTION IN PORTUGUESEBLOOD DONORSM. Queiros, C. Carvalho, S. Neto, J. Leal, P Mota, C. Moreira, C. Castro (IPS Centro Regionaldo Porto, Porto, Portugal)P-075 SEROLOGICAL AND MOLECULAR MARKERS OF HEPATITIS B VIRUSIN SPANISH BLOOD DONORS: EVIDENCE OF OCCULT HEPATITIS BS. Sauleda, R.M. Maymo, M. Piron, D. Candotti, J.P. Allain, J.M. Hernandez, L.l. Puig,N. Casamitjana (Banc de Sang i Teixits, Barcelona, Spain)P-068 EVALUATION OF THE COBAS TAQSCREEN MPX TEST FOR THESIMULTANEOUS DETECTION OF HCV, HBV, HIV-1 GROUP M, HIV-1 GROUPO AND HIV-2. EXPERIENCE OF THE PORTO REGIONAL BLOOD CENTREL. Queiros, A. Tender, A. Aguiar, J. Azevedo (Centro Regional de Sangue do Porto, Porto,Portugal)P-076 EPIDEMIOLOGY OF HIV, HCV AND HBV INFECTIONS IN ABOUT 1.4MILLION VOLUNTARY, NON-REMUNERATED BLOOD DONATIONS OF THEGERMAN RED CROSS BLOOD DONOR SERVICE BADEN-WUERTTEMBERG-HESSEN IN THE YEAR 2005.E. Schellenberg, S. Findhammer, K. Frank, K. Gubbe, A. Karl, G. Geusendam, A. Vosberg,T. Dengler, U. Mayr-Wohlfahrt, M. Loehr, E. Gruenelt, M. Schmidt, W. Sireis, E. Seifried(Red Cross Blood Donor Service Ba-Wue-He, Frankfurt am Main, Germany)76P-069 THE IMPORTANCE OF NEOPTERIN TESTING FOR DIAGNOSTICSA. Ragimov, N. Dashkova, N. Nikishova (National Research Center of Surgery, Moscow,Russian Federation)P-070 ANTI-HBC TESTING OF BLOOD DONORS IN INDIA - VALUE ANDFOLLOW-UP STRATEGIES TO IMPROVE BLOOD SAFETY WITH MINIMUMLOSSESH. Ranganathan, J. Diment, K. Kulathu, N. Iyer (Global Hospital, Hyderabad, India)P-071 HCV INFECTION IN MULTI-TRANSFUSED AND PUTATIVEIMMUNO-COMPROMISED PATIENTS IN ARGENTINAM.C.R. Remesar, C. Gamba, S. Oknaian, M. Batalla, A.E. Del Pozo (Hospital de PediatriaGarrahan, Buenos Aires, Argentina)P-072 EVALUATION OF A NEW HCV COMBINATION ASSAY INTHE TAIWANESE BLOOD DONOR POPULATIONC. Rodgers, K.T. Lin, Y.W. Wu, Y.J. Lee, J.W. Chen, K.C. Lin (Abbott Laboratories, Dartford,United Kingdom)P-073 EVALUATION AND ONE-YEAR EXPERIENCE USING HCV NAT BASEDON NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION FOR SCREENINGBLOOD DONATIONS IN ARGENTINAE. Rodriguez, A. Guichón, M.E. Acevedo, L. Tomasone, R.J. Fernández (FundaciónHemocentro Buenos Aires, Buenos Aires, Argentina)P-074 MOLECULAR EPIDEMIOLOGY OF HCV IN PORTUGALS.S. Sargento, A.M. Almeida, C. Ferreira, E. Silva, P. Neto, C. Colaborators (Hospitais daUniversidade de Coimbra, Coimbra, Portugal)P-077 ANTI-HBC SCREENING OF BLOOD DONORS - A COMPARISON OFSEVEN ANTI-HBC SCREENING ASSAYSM.S. Schmidt, M.K. Hourfar, A. Vosberg, T. Dengler, K. Janetzko, K. Gubbe, K. Frank, A. Karl,M. Loehr, E. Gruenelt, W. Sireis, W.K. Roth, E. Seifried, G. Geusendam (German Red CrossInstitute Frankfurt, Frankfurt, Germany)P-078 IMPLEMENTATION OF ANTI-HBC-TESTING INTO BLOOD DONORSCREENING IN GERMANYM.S. Schmidt, M.K. Hourfar, A. Vosberg, T. Dengler, K. Janetzko, K. Gubbe, K. Frank, A. Karl,M. Loehr, E. Gruenelt, W. Sireis, E. Seifried, G. Geusendam (German Red Cross InstituteFrankfurt, Frankfurt, Germany)P-079 PREVALENCE OF ANTI-HBC ANTIBODIES IN SWISS BLOOD DONORS,A 4 MONTH SURVEY AT THE BLOOD TRANSFUSION CENTER BASELC. Stebler, L. Infanti, B. Eiche, M. Santoro, C. Doepfner, T. Rüefli, M. Rüesch (BloodTransfusion Center Basel, Basel, Switzerland)P-080 TRANSFUSION OF BLOOD FROM TWO DANISH BLOOD DONORSINFECTED WITH HEPATITIS B VIRUS ESCAPE MUTANTS – DIFFERENTOUTCOME IN 10 RECIPIENTSH. Ullum, L. Harritshøj, U. Wend, P. Platz, H. Ring-Larsen, E. Dickmeiss, W.G. Wolfram(Rigshospitalet, Copenhagen, Denmark)P-081 HCV GENOTYPE DISTRIBUTION AMONG NORTHEAST-THAI BLOODDONORSY. Urwijitaroon, C. Sengthong, S. Barusrux (Fac.Associated Medical Sciences, Khon Kaen,Thailand)77INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT